Global Mobile C-Arm Market By Type (Full Size C-arm v/s Mini Size C-arm), By Technology (Flat Panel v/s Image Intensifiers), By Application (Orthopedics and Trauma, Cardiovascular, Urology, Gastroenterology, Neurology, Others), By End Users (Hospitals, Specialty Clinics, Ambulatory Surgical Clinics), By Region, Competition Forecast & Opportunities, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 1.98 Billion
CAGR (2026-2031)	5.63%
Fastest Growing Segment	Flat Panel
Largest Market	North America
Market Size (2031)	USD 2.75 Billion

Market Overview

The Global Mobile C-Arm Market will grow from USD 1.98 Billion in 2025 to USD 2.75 Billion by 2031 at a 5.63% CAGR. Mobile C-arms are flexible diagnostic imaging systems primarily utilized in operating theaters to provide real-time fluoroscopic visualization during orthopedic, cardiovascular, and trauma procedures. The market is fundamentally driven by the escalating global prevalence of chronic disorders and an aging demographic requiring surgical intervention, alongside a pivotal shift toward minimally invasive techniques that necessitate intraoperative guidance. Illuminating this rising demand, according to NHS England, in 2024, diagnostic imaging activity reached 47.2 million tests, representing an annual increase of 4.8%, while fluoroscopy procedures specifically grew by 2.0%. This utilization surge underscores the critical reliance on mobile imaging modalities to enhance surgical precision and patient outcomes.

Conversely, market expansion encounters a significant impediment regarding the substantial capital investment required for these advanced systems, coupled with budgetary constraints in healthcare institutions. High acquisition and maintenance costs often compel smaller facilities to delay equipment upgrades, thereby restricting the adoption of newer technologies. Furthermore, the longevity of existing hardware creates a replacement cycle that can slow rapid market penetration, challenging manufacturers to justify the return on investment for premium mobile C-arm configurations despite the clear clinical necessity.

Key Market Drivers

The rising prevalence of chronic diseases and orthopedic conditions is a primary catalyst for the Global Mobile C-Arm Market. As the geriatric population expands, the incidence of age-related ailments such as osteoarthritis and osteoporosis necessitates a higher volume of surgical interventions, particularly joint replacements and fracture repairs. Mobile C-arms are indispensable in these procedures, offering high-resolution real-time imaging that ensures accurate implant placement and reduces revision rates. Highlighting this trend, according to the American Joint Replacement Registry, October 2025, in the '2025 Annual Report', the cumulative number of reported hip and knee arthroplasty procedures reached more than 4.4 million, reflecting an 8.8% increase compared to the previous year. This surge in procedural volume directly correlates with the intensified utilization of mobile imaging units in operating rooms to manage the growing burden of musculoskeletal disorders.

Concurrently, the increasing global demand for minimally invasive surgical (MIS) procedures is reshaping market dynamics. Healthcare providers are prioritizing techniques that minimize patient trauma and accelerate recovery, which inherently rely on advanced fluoroscopic guidance provided by mobile C-arms. This shift is particularly evident in cardiovascular and spinal interventions where precision is paramount. Reflecting this robust demand for interventional solutions, according to Siemens Healthineers, November 2025, in the 'Q4 Fiscal Year 2025 Earnings Release', the Advanced Therapies segment recorded a comparable revenue growth of 3.8% year-over-year. Furthermore, broader market momentum is sustained by continued investment in medical infrastructure; according to GE HealthCare, October 2025, the company reported a total revenue increase of 6% year-over-year in the third quarter, driven by strong performance in imaging modalities. These indicators suggest a sustained trajectory of growth as facilities upgrade their diagnostic capabilities to support complex, minimally invasive workflows.

Download Free Sample Report

Key Market Challenges

The substantial capital investment required for advanced imaging systems, combined with stringent budgetary constraints in healthcare institutions, stands as a critical barrier impeding the Global Mobile C-Arm Market. Hospitals and outpatient facilities frequently operate with narrow financial margins, forcing decision-makers to scrutinize every capital expenditure. High acquisition and maintenance costs deter facilities from replacing aging equipment, leading them to extend the operational life of legacy hardware. This financial caution disrupts the natural replacement cycle and creates a significant bottleneck for market expansion, as the inability to secure funding delays the adoption of newer, clinically superior mobile C-arm configurations essential for complex procedures.

This trend of deferred investment is substantiated by recent industry data highlighting the severity of the financial pressure. According to the American Hospital Association, in 2025, approximately 94% of health care administrators expected to delay equipment upgrades to manage the financial strain caused by rising operational costs and tariff-related expenses. Such widespread postponement of purchasing decisions directly hampers manufacturers' ability to penetrate the market with premium technologies. Consequently, despite the rising clinical demand for intraoperative imaging, the market’s growth potential remains constricted by the economic inability of healthcare providers to justify the return on investment for new systems.

Key Market Trends

The Integration of Artificial Intelligence for Real Time Image Optimization and Analytics is fundamentally reshaping the market by addressing the dual challenges of operational efficiency and radiation safety. AI algorithms are increasingly embedded within mobile C arm systems to automate patient positioning and enhance image clarity, thereby reducing procedure times and cumulative dose exposure. This shift toward intelligent productivity is financially tangible for manufacturers as they prioritize automated workflow technologies to drive profitability. According to GE HealthCare, October 2024, in the 'Third Quarter 2024 Financial Results', the Imaging segment reported an 18% year over year increase in segment EBIT, a performance attributed to robust productivity initiatives that rely on these advanced and automated capabilities.

Concurrently, the Convergence of Mobile Imaging with Surgical Robotics and Navigation Systems is expanding the clinical utility of C arms beyond simple diagnostics into complex and intraoperative guidance. As procedures in spine and neurosurgery demand higher precision, mobile C arms are being engineered to seamlessly communicate with robotic platforms to create a unified ecosystem for instrument tracking and implant placement. This demand for integrated enabling technologies is evident in recent financial performances. According to Stryker, October 2024, in the 'Q3 2024 Earnings Call Transcript', the MedSurg and Neurotechnology segment delivered constant currency sales growth of 12.9%, underscoring the rapid adoption of systems that fuse visualization with surgical navigation.

Segmental Insights

The Flat Panel segment is currently the fastest-growing category in the Global Mobile C-Arm Market, driven by a definitive industry shift from traditional image intensifiers to digital detector technology. This expansion is primarily attributed to the superior diagnostic capabilities of flat panel systems, which deliver distortion-free, high-resolution imaging essential for precision in minimally invasive surgeries. Healthcare providers increasingly favor these units for their enhanced dose efficiency, which significantly lowers radiation exposure for patients and clinical staff. Furthermore, the inherent durability of flat panel detectors ensures consistent performance without the image degradation over time that characterizes older analog technologies.

Regional Insights

North America maintains a dominant position in the Global Mobile C-Arm Market, supported by established healthcare infrastructure and the widespread adoption of digital imaging technologies. This leadership is primarily driven by the increasing demand for minimally invasive procedures to treat chronic orthopedic and cardiovascular disorders, which are prevalent among the aging population. Furthermore, the region benefits from a streamlined regulatory environment where the U.S. Food and Drug Administration (FDA) plays a critical role in clearing new device technologies. These factors collectively foster a stable environment for ongoing market development and equipment modernization.

Recent Developments

• In November 2025, Shimadzu Medical Systems USA announced the commercial release of the SC15 mobile C-arm system in the United States market. This new fluoroscopy system was developed to deliver high-definition imaging for a variety of surgical applications, including orthopedics, pain management, and vascular procedures. The SC15 featured state-of-the-art flat panel detector technology and a high-power 15kW generator, enabling physicians to obtain clear, real-time images for assessing surgical progress. The system also included a large 43-inch primary monitor and a touch panel console designed to improve communication between surgical personnel and ensure a stress-free operating environment through intuitive control of imaging parameters.
• In November 2024, GE HealthCare introduced advanced imaging capabilities for its OEC 3D mobile C-arm portfolio, specifically targeting the practice of interventional pulmonology. The company launched the OEC 3D Lung Suite, which provided clinicians with augmented fluoroscopy and adjustable motorized 3D scanning to better visualize airway structures and verify tool placement during bronchoscopy procedures. Furthermore, the company expanded its OEC Open interface to allow seamless data transfer and integration with third-party robotic navigation systems. These enhancements were developed to provide precise, real-time 3D and 2D imaging, helping medical teams overcome challenges related to CT-to-body divergence and improving the accuracy of minimally invasive lung interventions.
• In March 2024, Siemens Healthineers secured Food and Drug Administration (FDA) clearance for the CIARTIC Move, a self-driving mobile C-arm designed to automate and standardize intraoperative imaging. The system was engineered to address operational challenges such as staff shortages and overloaded surgical teams by reducing the need for manual repositioning during procedures. It featured fully motorized wheels and a chassis that enabled precise, automated movements to stored positions, significantly accelerating 2D fluoroscopic and 3D cone-beam computed tomography workflows. This innovation allowed surgeons and operating room staff to reproduce images at specific angles effortlessly, enhancing consistency and efficiency in orthopedic, trauma, and spine surgeries.
• In February 2024, Royal Philips announced the global launch of the Zenition 90 Motorized mobile C-arm system, expanding its image-guided therapy portfolio to improved clinical workflows. This new system was designed to address complex vascular requirements and support a wide range of clinical procedures, including cardiac interventions, urology, and pain management. The device featured an intuitive motorized control mechanism that allowed surgeons to operate the C-arm from the table-side, thereby increasing flexibility and independence during operations. Additionally, the system incorporated automated workflows and advanced software solutions to deliver state-of-the-art image quality while prioritizing sustainability through improved power efficiency and extended product life.

Key Market Players

• Siemens Healthineers AG
• Koninklijke Philips N.V.
• General Electric Company
• Ziehm Imaging GmbH
• Shimadzu Corporation
• Canon Medical Systems Corporation
• Hologic, Inc.
• OrthoScan, Inc.
• Eurocolumbus S.r.l.
• Allengers Medical Systems Limited

By Type	By Technology	By Application	By End Users	By Region
Full Size C-arm v/s Mini Size C-arm	Flat Panel v/s Image Intensifiers	Orthopedics and Trauma Cardiovascular Urology Gastroenterology Neurology Others	Hospitals Specialty Clinics Ambulatory Surgical Clinics	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Mobile C-Arm Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Mobile C-Arm Market, By Type:

• Full Size C-arm v/s Mini Size C-arm

• Mobile C-Arm Market, By Technology:

• Flat Panel v/s Image Intensifiers

• Mobile C-Arm Market, By Application:

• Orthopedics and Trauma
• Cardiovascular
• Urology
• Gastroenterology
• Neurology
• Others

• Mobile C-Arm Market, By End Users:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Clinics

• Mobile C-Arm Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE